The International Association for the Study of Lung Cancer, (IASLC) International Congress on Advances in Pulmonary Neuroendocrine Tumors was a two-day meeting held at the Royal Brompton Hospital in London, United Kingdom on the thirteenth and forteenth of December 2007. The meeting was led by 14 member international faculty-in the disciplines of pathology, surgery, medicine, oncology, endocrinology, nuclear medicine, diagnostic imaging, and biostatistics. The aims were twofold, as an educational meeting, and to develop the IASLC International Pulmonary Neuroendocrine Tumors Registry. The meeting highlighted the difference in presentation of the tumors, management options for early and advanced stage disease including the use of novel agents and approaches. The need, process, and approach to an International Registry of Pulmonary Neuroendocrine Tumors were emphasized. International collaboration to develop a retrospective registry, prospective data collection, virtual tissue bank, and collaborative clinical trials were universally agreed as the best way to advance our understanding and treatment of these rare tumors.

, , , ,,
Journal of Thoracic Oncology
Department of Nuclear Medicine

Lim, E, Goldstraw, P, Nicholson, A.G, Travis, S.P.L, Jett, J.R, Ferolla, P, … Crowley, J. (2008). Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors 2007. Journal of Thoracic Oncology, 3(10), 1194–1201. doi:10.1097/JTO.0b013e3181861d7b